BI drug gets orphan status for MDS
admin 10th March 2017 Uncategorised 0Boehringer Ingelheim has bagged US orphan drug designation for its anti-CD33 monoclonal antibody BI 836858 for the treatment of myelodysplastic syndromes (MDS).
More: BI drug gets orphan status for MDS
Source: News